| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.6 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.09 |